Nuvectis Pharma Inc (NVCT)
6.145
-0.38
(-5.90%)
USD |
NASDAQ |
May 17, 16:00
6.145
0.00 (0.00%)
After-Hours: 20:00
Nuvectis Pharma Shareholders Equity (Quarterly): 14.02M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.02M |
| December 31, 2023 | 12.20M |
| September 30, 2023 | 16.69M |
| June 30, 2023 | 20.33M |
| March 31, 2023 | 12.27M |
| December 31, 2022 | 14.22M |
| Date | Value |
|---|---|
| September 30, 2022 | 20.37M |
| June 30, 2022 | 11.50M |
| March 31, 2022 | 14.56M |
| December 31, 2021 | -11.01M |
| September 30, 2021 | -8.932M |
| June 30, 2021 | -4.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.01M
Minimum
Dec 2021
20.37M
Maximum
Sep 2022
9.319M
Average
13.15M
Median
Shareholders Equity (Quarterly) Benchmarks
| Schrodinger Inc | 513.71M |
| CEL-SCI Corp | 14.30M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.71M |
| Total Liabilities (Quarterly) | 5.692M |